Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Rupprecht

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
MMW Fortschritte Der Medizin|October 21, 2004
[Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?]H J Rupprecht
MMW Fortschritte Der Medizin|August 3, 2007
[Coronary heart disease patient does not tolerate acetylsalicylic acid. Can clopidogrel be prescribed?]H J Rupprecht
Arzneimittel-Forschung|February 14, 1998
[Cardiology. II. Coronary heart disease, myocardial infarction]H J Rupprecht
MMW Fortschritte Der Medizin|April 19, 2005
[After the disappointing ASS primary prevention trial. "Holding back in women"]H J Rupprecht
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 3, 2006
[Cardiovascular secondary prevention]H-J Rupprecht
Krankenpflege Journal|November 1, 1988
[Current aspects of therapy for myocardial infarct]H J Rupprecht
EXS|September 21, 2000
Antithrombotic therapy in acute coronary syndromesM Buerke, H J Rupprecht
European Heart Journal|December 3, 1999
A plea for provisional stentingH J Rupprecht, J Meyer
Der Internist|May 8, 2002
[Modern reperfusion management in acute myocardial infarct]H J Rupprecht, J Meyer
Der Internist|February 18, 1998
[Conservative therapy of coronary heart disease. Conservative measures]H Darius, H J Rupprecht, J Meyer
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
MMW Fortschritte Der Medizin|October 21, 2004
[Interview with Prof. Dr. H. J. Rupprecht about secondary prevention: what is the optimal thrombocyte function inhibition?]H J Rupprecht
MMW Fortschritte Der Medizin|August 3, 2007
[Coronary heart disease patient does not tolerate acetylsalicylic acid. Can clopidogrel be prescribed?]H J Rupprecht
Arzneimittel-Forschung|February 14, 1998
[Cardiology. II. Coronary heart disease, myocardial infarction]H J Rupprecht
MMW Fortschritte Der Medizin|April 19, 2005
[After the disappointing ASS primary prevention trial. "Holding back in women"]H J Rupprecht
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 3, 2006
[Cardiovascular secondary prevention]H-J Rupprecht
Krankenpflege Journal|November 1, 1988
[Current aspects of therapy for myocardial infarct]H J Rupprecht
EXS|September 21, 2000
Antithrombotic therapy in acute coronary syndromesM Buerke, H J Rupprecht
European Heart Journal|December 3, 1999
A plea for provisional stentingH J Rupprecht, J Meyer
Der Internist|May 8, 2002
[Modern reperfusion management in acute myocardial infarct]H J Rupprecht, J Meyer
Der Internist|February 18, 1998
[Conservative therapy of coronary heart disease. Conservative measures]H Darius, H J Rupprecht, J Meyer
Pageof 16